Business Health WorldGSK in $350 million deal to develop cancer drugs with AdaptimmuneAbdul HafeezJune 2, 2014 by Abdul HafeezJune 2, 2014 LONDON: GlaxoSmithKline Plc GSK.L has agreed a deal worth more than $350 million (209 million pounds) with British biotech company Adaptimmune to develop cancer drugs...